tradingkey.logo
tradingkey.logo
Search

Altimmune Inc

ALT
Add to Watchlist
2.840USD
-0.140-4.70%
Close 07-31 16:00ETQuotes delayed by 15 min
552.31MMarket Cap
LossP/E TTM

ALT Financials

See Altimmune Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Altimmune Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.18/-0.25
Revenue / Forecast
0.00/830.00
Period
FY2025 Earnings
Revenue(YoY)
41.00K
105.00%
EPS(YoY)
-1.00
25.32%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
30.04%-0.18
20.55%-0.26
33.84%-0.21
21.76%-0.27
24.80%-0.26
39.83%-0.33
16.61%-0.32
-9.65%-0.35
13.97%-0.34
---0.54
---0.39
---0.32
---0.40
----
---1.37
----
----
----
----
----
Revenue
-100.00%0.00
420.00%26.00K
0.00%5.00K
0.00%5.00K
0.00%5.00K
-86.49%5.00K
-98.62%5.00K
-16.67%5.00K
-76.19%5.00K
133.64%37.00K
18000.00%362.00K
-25.00%6.00K
-34.38%21.00K
-103.36%-110.00K
-98.73%2.00K
-94.19%8.00K
-96.18%32.00K
41.72%3.28M
-94.64%157.56K
-80.93%137.62K
Net Profit
-15.26%-22.56M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.57M
26.74%-23.18M
-10.52%-22.84M
-53.42%-24.64M
-21.52%-24.39M
---31.64M
12.10%-20.67M
20.12%-16.06M
-3.31%-20.07M
----
29.83%-23.52M
19.01%-20.11M
-30.72%-19.43M
-124.91%-23.89M
-88.58%-33.51M
-48.07%-24.83M
Net Margin
----
77.30%-105223.08%
16.77%-380280.00%
10.12%-442920.00%
19.75%-391500.00%
-442.12%-463600.00%
-7901.44%-456900.00%
-84.10%-492800.00%
-410.39%-487880.00%
---85516.22%
---5710.22%
---267683.33%
---95590.48%
----
---150126.19%
----
----
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
--100.00%
----
----
----
----
----
Debt to assets ratio
--10.28%
--12.25%
--6.61%
--7.53%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-100.00%0.00
420.00%26.00K
0.00%5.00K
0.00%5.00K
0.00%5.00K
-86.49%5.00K
-98.62%5.00K
-16.67%5.00K
-76.19%5.00K
133.64%37.00K
18000.00%362.00K
-25.00%6.00K
-34.38%21.00K
-103.36%-110.00K
-98.73%2.00K
-94.19%8.00K
-96.18%32.00K
41.72%3.28M
-94.64%157.56K
-80.93%137.62K
Operating profit
-11.13%-24.24M
-16.19%-28.89M
15.78%-20.86M
14.29%-22.92M
18.58%-21.82M
-17.27%-24.87M
-9.88%-24.77M
-48.53%-26.75M
-23.14%-26.79M
8.18%-21.20M
8.94%-22.54M
11.71%-18.01M
-11.59%-21.76M
-11.65%-23.09M
25.46%-24.75M
-21.45%-20.39M
-31.20%-19.50M
-92.42%-20.68M
-81.20%-33.20M
8.82%-16.79M
Net Profit
-15.26%-22.56M
-18.02%-27.36M
16.77%-19.01M
10.12%-22.15M
19.75%-19.57M
26.74%-23.18M
-10.52%-22.84M
-53.42%-24.64M
-21.52%-24.39M
---31.64M
12.10%-20.67M
20.12%-16.06M
-3.31%-20.07M
----
29.83%-23.52M
19.01%-20.11M
-30.72%-19.43M
-124.91%-23.89M
-88.58%-33.51M
-48.07%-24.83M
Current assets
115.56%334.68M
102.68%278.19M
48.61%216.62M
10.07%188.42M
-17.20%155.26M
-34.52%137.25M
-4.71%145.76M
0.98%171.19M
8.32%187.51M
8.72%209.63M
-27.51%152.96M
-13.28%169.53M
-9.41%173.11M
-5.54%192.81M
-3.33%211.00M
-18.07%195.50M
-22.06%191.09M
-11.35%204.13M
0.06%218.26M
171.26%238.62M
Total current liabilities
15.56%11.32M
43.27%15.00M
45.94%12.61M
-39.16%9.22M
-13.54%9.80M
-13.79%10.47M
-27.23%8.64M
32.51%15.15M
-24.20%11.33M
-28.80%12.14M
-24.59%11.87M
-17.39%11.44M
-21.82%14.95M
-6.69%17.05M
-17.70%15.74M
52.21%13.85M
94.67%19.12M
52.04%18.28M
203.91%19.13M
84.99%9.10M
Total assets
113.42%335.63M
100.95%279.93M
47.74%218.45M
9.81%190.35M
-16.51%157.26M
-33.87%139.31M
-11.23%147.86M
-5.44%173.35M
0.68%188.36M
1.79%210.64M
-26.06%166.57M
-12.67%183.32M
-9.03%187.08M
-5.45%206.93M
-4.91%225.28M
-18.41%209.91M
-22.17%205.66M
-10.71%218.86M
1.68%236.91M
150.88%257.26M
Total liabilities
241.98%51.64M
248.38%55.04M
126.73%32.85M
39.24%28.98M
-2.08%15.10M
-4.49%15.80M
-10.44%14.49M
33.41%20.82M
-20.31%15.42M
-23.55%16.54M
-20.11%16.18M
1.50%15.60M
-6.93%19.35M
9.65%21.64M
-26.75%20.25M
-3.83%15.37M
16.72%20.79M
2.55%19.73M
-16.96%27.64M
-30.58%15.98M
Total equity
99.76%283.99M
82.09%224.89M
39.16%185.60M
5.79%161.37M
-17.80%142.16M
-36.37%123.51M
-11.32%133.38M
-9.05%152.53M
3.10%172.94M
4.75%194.10M
-26.65%150.40M
-13.79%167.71M
-9.27%167.73M
-6.95%185.29M
-2.02%205.03M
-19.37%194.53M
-24.98%184.87M
-11.84%199.13M
4.79%209.26M
203.41%241.28M
Net operating income
-24.36%-20.94M
-6.48%-19.45M
56.13%-11.90M
-6.86%-19.35M
-2.95%-16.84M
-10.48%-18.27M
-32.37%-27.12M
6.58%-18.11M
15.72%-16.36M
4.47%-16.53M
-36.13%-20.49M
-16.04%-19.38M
-43.48%-19.41M
21.22%-17.31M
15.33%-15.05M
11.74%-16.70M
30.88%-13.53M
-65.38%-21.97M
-87.01%-17.78M
-163.94%-18.93M
Net investment
27.66%-3.69M
-680.68%-79.16M
-12553.79%-149.32M
2835.58%101.11M
87.09%-5.10M
271.28%13.63M
-72.76%1.20M
-192.70%-3.70M
-397.11%-39.52M
-911.31%-7.96M
117.33%4.40M
108.14%3.99M
147900.00%13.30M
-96.06%981.00K
-237.97%-25.40M
-295.27%-48.97M
-100.05%-9.00K
167.21%24.87M
138.45%18.41M
311.22%25.08M
Net financing
130.00%78.47M
704.46%81.13M
14692.86%39.35M
113673.91%52.24M
13172.41%34.12M
-86.14%10.09M
-54.76%266.00K
-100.35%-46.00K
13.58%-261.00K
169295.35%72.75M
-98.17%588.00K
-39.47%13.06M
-109.49%-302.00K
-100.34%-43.00K
25663.21%32.06M
19.78%21.58M
-90.76%3.18M
-44.79%12.54M
-99.91%124.44K
-66.96%18.02M

FAQs

What is the total revenue of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total revenue reached 41.00K, with a year-on-year change of 20.00K.

What are the current assets of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its current assets were 278.19M, with a year-on-year change of 102.68.

What are the total assets of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total assets of Altimmune Inc were 279.93M, with a year-on-year change of 100.95.

What are the total liabilities of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total liabilities of Altimmune Inc were 55.04M, with a year-on-year change of 248.38.

What is the total equity of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its total equity of Altimmune Inc was 224.89M, with a year-on-year change of 82.09.

What is the net operating income of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net operating income of Altimmune Inc was -94.49M, with a year-on-year change of 8.42.

What is the net investment of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net investment of Altimmune Inc was -132.47M, with a year-on-year change of -366.68.

What is the net financing of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net financing of Altimmune Inc was 206.84M, with a year-on-year change of 1959.36.

What is the Earnings Per Share (EPS) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.00, with a year-on-year change of 25.32.

What is the net income of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net income was -88.09M, with a year-on-year change of 7.33.

What is the net margin of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its net profit margin was -214860.98, with a year-on-year change of 54.79.

What is the Return on Equity (ROE) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Return on Equity (ROE) was -50.57, with a year-on-year change of 15.52.

What is the Return on Assets (ROA) of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.03, with a year-on-year change of 22.64.

What is the operating profit of Altimmune Inc?

According to Altimmune Inc's FY2025 earnings report, its operating profit was -94.49M, with a year-on-year change of 8.42.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.